Theralase Discovers Anti-Cancer Drug Fluoresces in Tissue
ACCESSWIRE - Thu May 14, 6:03AM CDT
TORONTO, ON / ACCESSWIRE / May 14, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company"
TLT.VN: 0.365 (-0.055)
Theralase Manufactures High Purity Anti-Cancer Drug
Filing Services Canada XHTML - Tue May 12, 6:02AM CDT
TLT.VN: 0.365 (-0.055)
Theralase 2014 Annual Results: Maintaining Buy Recommendation
Anita Dushyanth - at Seeking Alpha - Tue May 05, 8:51AM CDT
Pain Management Devices - Global Strategic Business Report 2015 - Neurostimulation Devices: The Future of Pain Management?
M2 - Tue May 05, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bzbgcw/pain_management) has announced the addition of the "Pain Management Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Pain Management Devices in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 34 companies including many key and niche players such as: - Bio-Medical Research (BMR) Ltd. (Ireland) - Boston Scientific Corp. (US) - Codman & Shurtleff, Inc. (US) - DJO Global, Inc. (US) - Halyard Health (US) - Medtronic, Inc. (US) - Smiths Medical (UK) - St. Jude Medical, Inc. (US) - NeuroTherm? (US) - Stryker Corporation (US) - Theralase Technologies Inc. (Canada) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS/DRIVERS & ISSUES 3. LEADING PAIN MANAGEMENT DEVICE TYPES 4. PRODUCT OVERVIEW 5. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT GLOBAL PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 34 (including Divisions/Subsidiaries - 35) - The United States (25) - Canada (1) - Europe (7) - - France (1) - - The United Kingdom (2) - - Italy (1) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (2) For more information visit http://www.researchandmarkets.com/research/bz...management
HYH: 42.35 (-0.75), BSX: 17.85 (-0.06), MDT: 76.42 (+0.16), STJ: 74.96 (+0.47), SYK: 95.51 (+0.25)
Theralase Increases Revenue 15% in 2014 Financials
ACCESSWIRE - Fri May 01, 9:14AM CDT
TORONTO, ON / ACCESSWIRE / May 1, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company"
TLT.VN: 0.365 (-0.055)
Theralase Manufactures First Pre-Commercial Batch of Lead Anti-Cancer Drug
ACCESSWIRE - Thu Apr 09, 6:05AM CDT
TORONTO, ON / ACCESSWIRE / April 9, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company"
TLT.VN: 0.365 (-0.055)
Theralase Holds pre-CTA Meeting with Health Canada
ACCESSWIRE - Thu Apr 02, 6:15PM CDT
TORONTO, ON / ACCESSWIRE / April 2, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company"
TLT: 121.59 (+2.39), TLT.VN: 0.365 (-0.055)
Theralase Partners with CiToxLAB for Toxicology
ACCESSWIRE - Mon Mar 23, 6:05AM CDT
TORONTO, ON / ACCESSWIRE / March 23, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company"
TLT.VN: 0.365 (-0.055)
Theralase Confirms Strategic Initiatives
ACCESSWIRE - Wed Mar 11, 6:21AM CDT
TORONTO,ON / ACCESSWIRE / March 11, 2015 / Theralase Technologies Inc. ("Theralase" or the "Company"
TLT.VN: 0.365 (-0.055)
Theralase's Lead Anti-Cancer Drug Has Significantly Less Skin Toxicity than FDA Approved Drug
ACCESSWIRE - Fri Feb 13, 6:04AM CST
Toronto, ON / ACCESSWIRE / February 13, 2015 / Theralase Technologies Inc. ("Theralase"
TLT.VN: 0.365 (-0.055)
Theralase Ranked in 2015 Toronto Stock Exchange Venture 50(tm)
ACCESSWIRE - Wed Feb 11, 8:19AM CST
Toronto, ON / ACCESSWIRE / February 11, 2015 / Theralase Technologies Inc. ("Theralase"
TLT.VN: 0.365 (-0.055)